Dual antiplatelet treatment after stenting: is longer better?

Dual antiplatelet treatment after stenting: is longer better?

Extension of DAPT might mitigate risk of stent thrombosis or subsequent thrombotic events elsewhere in the circulation. However, it will also increase bleeding risk and costs. Therefore, a key question that remained to be addressed by adequately powered clinical trials is whether or not extension of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2014-11, Vol.384 (9954), p.1553-1555
Hauptverfasser: Sibbing, Dirk, Massberg, Steffen
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Blood platelets
Cardiovascular disease
Clinical trials
Coronary Artery Disease - therapy
Coronary vessels
Drug therapy
Drug-Eluting Stents
Female
Humans
Internal Medicine
Male
Mortality
Patients
Platelet Aggregation Inhibitors - administration & dosage
Risk reduction
Stents
Thromboembolism
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Extension of DAPT might mitigate risk of stent thrombosis or subsequent thrombotic events elsewhere in the circulation. However, it will also increase bleeding risk and costs. Therefore, a key question that remained to be addressed by adequately powered clinical trials is whether or not extension of DAPT beyond 1 year after PCI provides any net clinical benefit.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(14)60768-6